IPHYF Form 6-K: Report of foreign private issuer

Innate Pharma SA Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

2026-09-17: Form 6-K; Period of report 2026-09-17; Description 6-K; Document a6kseptember172026.htm.
2026-09-17: Form 6-K; Period of report 2026-09-16; Description 6-K; Document a6kseptember1620261.htm.
2026-09-17: Form 6-K; Period of report 2026-06-30; Description 6-K; Document inpha-20260630.htm.
2026-09-10: Form 6-K; Period of report 2026-09-10; Description 6-K; Document a260910_6k.htm.

Filed	Form	Period of report	Description	Document
2026-09-17	6-K	2026-09-17	6-K	a6kseptember172026.htm
2026-09-17	6-K	2026-09-16	6-K	a6kseptember1620261.htm
2026-09-17	6-K	2026-06-30	6-K	inpha-20260630.htm
2026-09-10	6-K	2026-09-10	6-K	a260910_6k.htm
2026-09-02	6-K	2026-09-02	6-K	a260902_6k.htm
2026-08-19	6-K	2026-08-19	6-K	a260819_6k1.htm
2026-08-14	6-K	2026-08-14	6-K	a260814_6k.htm
2026-08-10	6-K	2026-08-10	6-K	a6kincorporatediph-praug10.htm
2026-07-23	6-K	2026-07-23	6-K	a260723_6k.htm
2026-07-21	6-K	2026-07-21	6-K	a2607216kincorporatediph1.htm
2026-05-22	6-K	2026-05-22	6-K	a260522_6k.htm
2026-05-19	6-K	2026-05-19	6-K	a260519_6k.htm
2026-05-13	6-K	2026-05-13	6-K	a2605136kincorporatediph.htm
2026-05-12	6-K	2026-05-12	6-K	a6k-iphx260512.htm
2026-05-06	6-K	2026-05-06	6-K	a260506_6k.htm
2026-04-23	6-K	2026-04-23	6-K	a6k-iphx260423.htm
2026-04-17	6-K	2026-04-17	6-K	a2604176kincorporatediph.htm
2026-04-13	6-K	2026-04-13	6-K	a6k-iphx2604132.htm
2026-04-13	6-K	2026-04-13	6-K	a6k-iphx260413.htm
2026-04-08	6-K	2026-04-08	6-K	a260408_6k-iph.htm
2026-04-03	6-K	2026-04-03	6-K	a6k-iphx260403.htm
2026-04-02	6-K	2026-04-02	6-K	a6k-iphx260402.htm
2026-03-26	6-K	2026-03-26	6-K	a2603266kincorporatediph.htm
2026-03-19	6-K	2026-03-19	6-K	a6k-iphx260319.htm
2026-02-18	6-K	2026-02-18	6-K	a6k-iphx260218.htm
2026-01-07	6-K	2026-01-07	6-K	a260107_6k-iph.htm